BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22440247)

  • 1. Neoadjuvant chemotherapy rather than neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer with high tumor burden.
    Koca D; Oztop J; Yilmaz U
    Hepatogastroenterology; 2012 Oct; 59(119):2151-4. PubMed ID: 22440247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neo adjuvant chemo-radiotherapy and rectal cancer: can India follow the West?
    Bansal V; Bhutani R; Doval D; Kumar K; Pande P; Kumar G
    J Cancer Res Ther; 2012; 8(2):209-14. PubMed ID: 22842363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
    Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
    J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term results and long-term oncologic outcomes between neoadjuvant chemoradiotherapy and adjuvant postoperative chemoradiotherapy for stage III rectal cancer: a case-matched study.
    Kang J; Jang SM; Baek JH; Lee WS; Cho TH
    Ann Surg Oncol; 2012 Aug; 19(8):2494-9. PubMed ID: 22476817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
    Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
    Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
    Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
    Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
    Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
    Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
    Martijnse IS; Dudink RL; Kusters M; Vermeer TA; West NP; Nieuwenhuijzen GA; van Lijnschoten I; Martijn H; Creemers GJ; Lemmens VE; van de Velde CJ; Sebag-Montefiore D; Glynne-Jones R; Quirke P; Rutten HJ
    Ann Surg Oncol; 2012 Feb; 19(2):392-401. PubMed ID: 21792506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
    Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.
    John AO; Singh A; Bala D; Joel A; Georgy JT; Jesudasan MR; Mittal R; Ram TS; Reddy JR; Murthy A; Chandramohan A; Eapen A; Masih D; Ramnath N; Dobrosotskaya I; Yadav B; Chacko RT
    J Gastrointest Cancer; 2024 Mar; 55(1):307-317. PubMed ID: 37479897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.